1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results.

MM - 1195

The Urban Paradox: Intersectional Mortality Disparities and the Geographic Divide in Early-Onset Multiple Myeloma (1999-2020)

Nihar Prafullchandra Vavaliya

Poster Presenter: Nihar Prafullchandra Vavaliya

Thumbnail for Comparative Performance of Artificial Intelligence/Machine Learning Versus Conventional Prognostic Models in Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 1197

Comparative Performance of Artificial Intelligence/Machine Learning Versus Conventional Prognostic Models in Multiple Myeloma: A Systematic Review and Meta-Analysis

Sangeeth Pradeep

Poster Presenter: Sangeeth Pradeep

MM - 1202

Real-World Survival and Safety of Isatuximab-Based vs Daratumumab-Based VRd Exposure in Multiple Myeloma

Xiaoyi Zhang

Poster Presenter: Xiaoyi Zhang

Thumbnail for Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

MM - 1205

Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

Sukhmani Sidhu

Poster Presenter: Sukhmani Sidhu

Thumbnail for The Urban Concentration of Premature Mortality: Evaluating the Disproportionate Mortality Burden in Early-Onset (<55) Multiple Myeloma in the Modern Era

MM - 1213

The Urban Concentration of Premature Mortality: Evaluating the Disproportionate Mortality Burden in Early-Onset (<55) Multiple Myeloma in the Modern Era

Nihar Prafullchandra Vavaliya

Poster Presenter: Nihar Prafullchandra Vavaliya

$Thumbnail for Arlocabtagene Autoleucel, a GPRC5D-Targeted CAR T-Cell Therapy for Patients With Relapsed/Refractory Multiple Myeloma: Updated Phase 1 Safety and Efficacy Results in Patients With 1-3 Prior Regimens$

MM - 1223

Arlocabtagene Autoleucel, a GPRC5D-Targeted CAR T-Cell Therapy for Patients With Relapsed/Refractory Multiple Myeloma: Updated Phase 1 Safety and Efficacy Results in Patients With 1-3 Prior Regimens

Susan Bal

Poster Presenter: Susan Bal

Thumbnail for Frailty as an Independent Determinant of Inpatient Mortality and Discharge Transitions in Multiple Myeloma: A Nationwide Analysis Using the Hospital Frailty Risk Score

MM - 1224

Frailty as an Independent Determinant of Inpatient Mortality and Discharge Transitions in Multiple Myeloma: A Nationwide Analysis Using the Hospital Frailty Risk Score

Aayushi Pareek

Poster Presenter: Aayushi Pareek

Thumbnail for GLP-1 Agonists Improve Survival and Reduce Morbidity in Newly Diagnosed Multiple Myeloma: A Real-World Propensity Score-Matched Analysis

MM - 1225

GLP-1 Agonists Improve Survival and Reduce Morbidity in Newly Diagnosed Multiple Myeloma: A Real-World Propensity Score-Matched Analysis

Chidiebube Ugwu

Poster Presenter: Chidiebube Ugwu

Thumbnail for In-Hospital Outcomes and Resource Utilization of Admissions With Sepsis Across Hematologic Malignancy Subtypes: A National Inpatient Sample Analysis (2016-2022)

MM - 1232

In-Hospital Outcomes and Resource Utilization of Admissions With Sepsis Across Hematologic Malignancy Subtypes: A National Inpatient Sample Analysis (2016-2022)

Ekow Pinkrah

Poster Presenter: Ekow Pinkrah